Lamotrigine
CAS No. 84057-84-1
Lamotrigine ( BW 430C; Epilepax; Lamictal; LTG )
产品货号. M16122 CAS No. 84057-84-1
Lamotrigine is an anticonvulsant drug used in the treatment of epilepsy and bipolar disorder.
纯度: >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
200MG | ¥251 | 有现货 |
|
500MG | ¥373 | 有现货 |
|
1G | ¥583 | 有现货 |
|
生物学信息
-
产品名称Lamotrigine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Lamotrigine is an anticonvulsant drug used in the treatment of epilepsy and bipolar disorder.
-
产品描述Lamotrigine is an anticonvulsant drug used in the treatment of epilepsy and bipolar disorder. For epilepsy it is used to treat partial seizures, primary and secondary tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. Lamotrigine also acts as a mood stabilizer. It is the first medication since lithium granted Food and Drug Administration (FDA) approval for the maintenance treatment of bipolar type I. Chemically unrelated to other anticonvulsants, lamotrigine has relatively few side-effects and does not require blood monitoring.
-
同义词BW 430C; Epilepax; Lamictal; LTG
-
通路Endocrinology/Hormones
-
靶点5-HT Receptor
-
受体5-HT (human platelets); 5-HT (rat brain synaptosomes)
-
研究领域Neurological Disease
-
适应症——
化学信息
-
CAS Number84057-84-1
-
分子量256.09
-
分子式C9H7Cl2N5
-
纯度>98%(HPLC)
-
溶解度Ethanol: 3 mg/mL (11.71 mM); DMSO: 10 mg/mL (39.04 mM)
-
SMILESNC1=NC(N)=C(C2=CC=CC(Cl)=C2Cl)N=N1
-
化学全称6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Lipkind GM, et al. Mol Pharmacol. 2005 Dec;68(6):1611-22.
产品手册
关联产品
-
Nafronyl oxalate
A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic.
-
ST1936 oxalate
ST1936 oxalate is a selective, nanomolar affinity agonist of 5-HT6 receptor.
-
Pergolide mesylate s...
PERGOLIDE MESYLATE is a long-acting dopamine agonist which has been used to treat parkinson disease and hyperprolactinemiabut withdrawn from some markets due to potential for heart valve diseases.